ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
First Patient Dosed in Avatrombopag Study ITP in Children americanpharmaceuticalreview
March 22, 2021Swedish Orphan Biovitrum announced the first patient has been dosed with avatrombopag, a thrombopoietin receptor agonist (TPO-RA), for treatment of immune thrombocytopenia (ITP) in pediatric patients.
Pharma Sources Insight January 2025
